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Abstract
Background—Chronic ethanol consumption causes alcoholic liver disease (ALD) and disruption 
of the circadian system facilitates the development of ALD. Small heterodimer partner (SHP) is a 
nuclear receptor and critical regulator of hepatic lipid metabolism. This study aims at depicting 
circadian metabolomes altered by chronic ethanol-plus-binge and Shp-deficiency using high 
throughput Metabolomics.
Methods—Wild-type (WT) C57Bl/6 and Shp-/- mice were fed the control diet (CD) or Lieber 
De-Carli ethanol liquid diet (ED) for 10 days followed by a single bout of maltose (CD+M) or 
ethanol (ED+E) binge on the 11th day. Serum and liver were collected over a 24 hr light-dark (LD) 
cycle at Zeitgeber time ZT12, ZT18, ZT0 and ZT6 and metabolomics was performed using GC-
MS.
Results—A total of 110 metabolites were identified in liver and of those 80 were also present in 
serum from pathways of carbohydrates, lipids, pentose phosphate, amino acids, nucleotides and 
tricarboxylic acid (TCA) cycle. In the liver, 91% of metabolites displayed rhythmicity with ED+E 
whereas in the serum, only 87% were rhythmic. Bioinformatics analysis identified unique 
metabolome patterns altered in WT CD+M, WT ED+E, Shp-/- CD+M, and Shp-/- ED+E groups. 
Specifically, metabolites from the nucleotide and amino acid pathway (ribose, glucose-6-
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phosphate, glutamic acid, aspartic acid and seduheptulose-7-P) were elevated in Shp-/- CD+M 
mice during the dark cycle, whereas metabolites including N-methylalanine, 2-hydroxybutyric 
acid, 2-hydroxyglutarate were elevated in WT ED+E mice during the light cycle. The rhythmicity 
and abundance of other individual metabolites were also significantly altered by both control and 
ethanol diets.
Conclusions—Metabolomics provides a useful means to identify unique metabolites altered by 
chronic ethanol-plus-binge.
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Introduction
The circadian system plays a pivotal role in coordinating the daily actions of physiology, 
behavior and metabolism (Adamovich et al., 2014, Huang et al., 2011). In mammals, 
circadian rhythms are under the control of a core circadian clock located in the 
suprachiasmatic nucleus (SCN) of the anterior hypothalamus (Panda et al., 2002). The SCN 
integrates a number of signals, such as feeding and light, and operates as a synchronizer for 
a multitude of peripheral clocks located in most tissues including liver, fat and muscle. 
Accumulative evidence demonstrates that a wide range of metabolic pathways are controlled 
by the circadian system and its disruption can evoke dysregulation of lipid metabolism, 
obesity and metabolic disease (Froy, 2010). Consequently, disruption of clock gene function 
in genetic mouse models results in impaired lipid metabolism (Turek et al., 2005, Oishi et 
al., 2006). The liver is an essential organ carrying out a number of biological processes 
underlying systemic energy regulation, metabolism, detoxification and hormonal 
productions, thus proper timing is key to maintenance of homeostasis in the system.
It has been well documented that chronic ethanol consumption causes steatosis and 
inflammation in rodents via disruption of key transcriptional regulators to facilitate the 
development of alcoholic fatty liver (AFL) (Fengler et al., 2016, You et al., 2008). In 
particular, exposure to ethanol has been reported to alter expression of lipid metabolism 
genes in livers of Clock mutant mice leading to the accumulation of lipids (Kudo et al., 
2009) and disrupting the circadian rhythm of wildtype mice (Seggio et al., 2009).
The small heterodimer partner (SHP, NR0B2) is a unique nuclear receptor (Rudraiah et al., 
2016) and a key transcription factor of genes involved in whole body and hepatic lipid 
metabolism (Huang et al., 2010, Huang et al., 2007, Wang et al., 2005, Tabbi-Anneni et al., 
2010) and of circadian rhythms in the liver (Pan et al., 2010, Zhang et al., 2011b). Due to its 
lack of DNA binding domain, Shp exerts its transcriptional repression through protein-
protein interactions with other nuclear receptors (Datta et al., 2006, Matsukuma et al., 2007, 
Zhou et al., 2010) and transcription factors (Zhang et al., 2014, Suh et al., 2006, Zhang et al., 
2012). Shp-deficiency in mice has recently been shown to alter the rhythmicity of liver 
metabolic genes (Zhang et al., 2011a) by serving as an integral component of the liver 
circadian network to maintain hepatic lipid and homocysteine homeostasis (Lee et al., 2015, 
Tsuchiya et al., 2015). Furthermore, major genes regulating ethanol metabolism, Adh1 and 
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Adh2, were upregulated in livers of ethanol-fed Shp-/- mice, pertinent to its role in ethanol 
catabolism (Park et al., 2016). Most recently, we used a modified chronic ethanol-binge 
model (Bertola et al., 2013) to examine cyclic lipid alterations in wild-type (WT) and Shp-/- 
mice over a 24 hr period and observed distinct responses in WT and Shp-/- mice upon 
ethanol diet plus ethanol-binge (ED+E) or control diet plus maltose-binge (CD+M) (Yang et 
al., 2016, The American Journal of Pathology, in press). In order to better understand the 
impact of ED+E vs CD+M in ALF, further study is needed to determine the rhythmicity of 
metabolic pathways controlled by alcohol and Shp.
Majority of the circadian research have largely focused on dissecting out transcriptome 
expression profiles of core clock and output genes involved in lipid metabolism (Udoh et al., 
2015, Smalling et al., 2013). However, this provides only a partial depiction of the changes 
in metabolic pathways involved as many processes are regulated beyond the transcriptional 
level. Limited studies however, have proceeded to screen other metabolic pathways and their 
products (including pathways of amino acids, carbohydrates and nucleotides) oscillating 
throughout the day (Abbondante et al., 2016, Eckel-Mahan et al., 2012). The present study 
took a novel and high-throughput approach to assess the oscillatory profile of metabolites in 
WT and Shp-/- mice fed with ED+E or CD+M using metabolomics analysis. The critical role 
of Shp in the metabolome associated with the deleterious effect of alcohol provides a 
therapeutic and preventative insight into the diagnosis and development of ALF.
Materials and Methods
Animals and diet
Male C57Bl/6 control and Shp-/- mice (Wang et al., 2002) of 8-10 weeks of age were housed 
individually in an environmentally controlled room and maintained on a 24h light/dark (LD) 
cycle (lights on at 6 am to 6 pm) with free access to water and food. Mice were fed a control 
liquid diet for 5 days to acclimatize to the liquid diet and tube feeding regime. After the 
acclimation period, mice were given either a control diet (Bio-Serv, product #F1259SD) or 
5% Lieber-DeCarli ethanol liquid diet (Bio-Serv, product #F1258SP) for 10 days with diets 
changed daily at 5 pm as described previously (Tsuchiya et al., 2015). On the 11th day at 9 
am, mice were gavaged with a single dose of maltose dextrin (Control, 9 g maltose dextrin 
per kg of body weight) or ethanol (5 g ethanol per kg of body weight), respectively. Nine 
hours after the binge, mice (n=3 per group per genotype) were euthanized and serum and 
liver collected every 6 hr over a 24h LD cycle at Zeitgeber time (ZT) ZT12, ZT18, ZT0 and 
ZT6. Both control and ethanol diets were provided throughout the sample collection period 
after the binge. A dim red light at intensity of 1 μmol/m2s was used to collect tissues in dark 
conditions. All experimental procedures were approved and performed according to the 
standards of the Institutional Animal Care and Use Committee (IACUC) and The University 
of Connecticut.
Metabolomics analyses
The metabolomics analysis was conducted by the Metabolomics Core at the University of 
Utah. A Waters GCT Premier mass spectrometer fitted with an Agilent 6890 gas 
chromatograph and a Gerstel MPS2 auto sampler was used for GC-MS analysis. A 
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commercially available NIST library and pure purchased standards were used to determine 
metabolite identity. The data was normalized by means entering to the internal standard d4-
succinate.
Data Analyses
Values are presented as means ± SEM (n=3/group). All data were analyzed by a students' t-
test and P<0.05 was considered statistically significant. For heatmap clustering and boxplots, 
a one-way ANOVA was performed to determine the differential expression of selected 
metabolites.
Results
Comparative circadian metabolomics profile
The Gao-binge model closely resembles the drinking behavior and of acute chronic liver 
injury in patients with ALD (Bertola et al., 2013), thus we used this model to understand the 
circadian rhythmicity of metabolomes. In order to identify the relative abundance of cyclic 
metabolites throughout the circadian cycle, serum and liver samples from WT and Shp-/- 
mice that were fed ED+E or CD+M were collected at four time points over an entire 24 hr 
light/dark cycle.
Metabolomics analyses by GC-MS identified about 110 known metabolites in the liver 
belonging to major metabolic pathways such as carbohydrates, lipids, pentose phosphate, 
amino acids, nucleotides and tricarboxylic acid (TCA) cycle pathways (Table 1). Although a 
large fraction of metabolites was also identified in serum, only 80 of these metabolites 
(∼73%) were found to be present in serum compared to the liver. The total number of 
carbohydrate and lipid metabolites identified in serum was relatively less compared to its 
presence in the liver (Table 1). In the carbohydrate pathway, only 10 (50%) of these were 
detected in the serum. In the liver, a large proportion of metabolites (91%) displayed 
rhythmicity with chronic ethanol feeding whereas in the serum, only 87% were rhythmic. 
Analyses of amino acids revealed that a total of 29 amino acid metabolites were present in 
both serum and liver (Table 1). In addition, a similar number of metabolites from the pentose 
phosphate, urea and TCA pathway were identified in serum and liver (Table 1). Of the total 
number of nucleotide metabolites identified following metabolome analyses, only 54% of 
these were found to be in the serum compared with the liver.
Distinct cyclic pathways altered by maltose, ethanol and Shp-deficiency using 
bioinformatics analysis
The metabolomics data were subjected to non-supervised multivariate data analysis to 
identify unique metabolome patterns altered in WT CD+M, WT ED+E, Shp-/- CD+M, and 
Shp-/- ED+E groups. Correlation matrix clustering showed subsets of metabolites with 
strong correlation at each ZT time (Supp Figure S1-S4). PLS-DA scores plots revealed a 
maximal to minimal separation of metabolites among the four groups from the circadian 
dark phase between ZT12 (6 pm) and ZT18 (12 am) to light phase between ZT0 (6 am) and 
ZT6 (12 pm) (Figure 1A), indicating the effects of light (day) as well as food intake (night) 
on metabolic profiles.
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Distinct metabolites were further visualized by Heatmap clustering. Interestingly, during the 
dark cycle between ZT12 and ZT18, Shp-/- CD+M mice had increased levels of metabolites 
from the nucleotide and amino acid pathway including ribose, glucose-6-phosphate, 
glutamic acid, aspartic acid and seduheptulose-7-P compared with other three groups 
(Figure 1B, left two panels, red box). In contrast, WT ED+E mice displayed several high 
levels of amino acid, TCA and lipid metabolites compared with other groups during the light 
cycle (ZT0 and ZT6) (Figure 1B, right two panels), which continued to onset of dark cycle 
at ZT12. It was also noted that some low levels of metabolites observed in WT ED+E at ZT0 
(green box) (ribose, glutamic acid, aspartic acid) remained at constant low levels at other 
time points (Figure 1B). The differential expression of selected metabolites was elucidated 
by one-way ANOVA and boxplots (Supp Figure S5-S8).
Amino acid, nucleotide and lipid pathways differentially altered by maltose control and 
ethanol diets in Shp-/- serum
While only 73% (80 out of 110 metabolites) of overall circulating metabolomes were found 
in serum compared with liver, there are indeed striking differences between the two samples. 
Overall, more circulating serum metabolites from carbohydrate, amino acids, nucleotides, 
lipids and pentose phosphate pathway displayed loss of rhythmicity compared with the liver. 
Furthermore, differences were observed under ED+E or CD+M feeding conditions between 
WT and Shp-/- mice. Under CD+M conditions, Shp-/- mice had reduced amino acid (valine, 
threonine, methionine, homoserine, 4-aminobutyrate, β-alanine, aminomalonic acid and 4-
hydroxyproline) metabolite levels during the dark phase. In particular, the levels were 
significantly reduced at ZT12, which was in contrast to their expected night time feeding 
behavior, whereas WT mice had increased levels (Figure 2A). In order to interpret the cyclic 
circadian pattern between WT and Shp-/- mice fed the control maltose or ethanol diet, a 
double plot was presented to represent these distinct changes. Aspartic acid and glutamic 
acid metabolite levels showed high to moderate rhythmicity in WT mice, where their 
amplitude was substantially increased in mice with Shp-deficiency during the dark phase 
from ZT12 to ZT18 (Figures 2B). Ribose, seduheptulose-7-phosphate, and phosphate 
metabolite levels from the nucleotide pathway were also significantly altered in Shp-/- mice 
that were fed CD+M during the onset of the dark phase (Figure 2C), as reflected by both 
increased amplitude as well as a shift in circadian phase.
In response to ED+E feeding, Shp-/- mice had elevated levels of lipid metabolites (1-
monoolenoylglycerol, phosphoethanolamine and 1-phosphoglycerol) at the onset of the dark 
phase at ZT12 compared with WT mice (Figure 2D). Additionally, ribose metabolite levels 
had no obvious rhythmicity in WT mice, while their levels showed a clear circadian 
oscillation due to increased amplification during the dark phase in Shp-/- mice (Figure 2E). 
Interestingly, Shp-/- mice had slightly higher magnitude of oscillation of circulating aspartic 
acid, glutamic acid, and tyrosine during the onset of light conditions compared with WT 
mice (Figure 2F), which caused enhanced amplification. In addition, plasma ornithine and 
tryptophan levels showed strong rhythmicity shift of the circadian cycle to the right in Shp-
deficient mice (Figure 2F).
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Oscillatory liver metabolic pathways altered by maltose diet in Shp-/- mice
WT mice that were fed CD+M had more pronounced effects on the carbohydrate pathway 
compared with the amino acids, lipid and nucleotide pathways in the liver (Figure 3). 
Indeed, carbohydrate metabolite levels of fructose, galactose and GalNac showed similar 
circadian rhythmicity which peaked during the dark phase in WT mice (Figure 3A), 
consistent with the composition of the control diet as well as increased activity and eating 
habits during the night cycle. In contrast, these metabolites in Shp-/- had reduced amplitude 
and blunted circadian rhythmicity (Figure 3A). Similarly, circadian rhythmicity of ribose 
and sedoheptulose-7-phosphate from the pentose pathway and uracil, adenosine, 
hypoxanthine, adenine and uric acid from the nucleotides pathway were similar despite 
reduced amplitude and circulating metabolite levels in Shp-/- mice compared with WT mice 
(Figures 3B-3C). Additionally, there was a decrease in oscillatory amplitude of palmitiladic 
acid, linoleic acid, 1-monolinoleoylglycerol and 1-monopalmitolylglycerol in Shp-/- mice 
(Figure 3D). Majority of metabolites from the carbohydrate, lipid and nucleotide pathways 
from Shp-/- mice lack strong rhythmicity under CD+M conditions in contrast to WT mice 
who displayed strong rhythmicity (Figures 3B-3D). Similar to serum levels, glutamic acid in 
the liver showed a significant shift in circadian phase where metabolite levels were elevated 
in Shp-/- mice during the dark phase and reduced at the onset of the light phase compared 
with WT mice (Figure 3E).
Oscillatory liver metabolic pathways altered by ethanol diet in Shp-/- mice
Mice fed ED+E displayed rhythmicity in their lipid pathway but the amplitude and 
expression levels were lower (linoleic acid, oleic acid, elaidic acid, 1-monolinoleoylglycerol 
and 2-hydroxybutyric acid) in Shp-/- mice, which was significant at the beginning of the dark 
phase (ZT12) (Figure 4A). Furthermore, Shp-/- mice had low rhythmicity throughout the 24 
hr light-dark cycle in contrast to the strong rhythmicity of WT mice (Figure 4A). The 
circadian profile from the nucleotide pathway showed a shift of circadian phase of adenine, 
ribose and hypoxanthine in Shp-/- mice where levels were higher at the onset of the light 
phase compared with WT mice (Figure 4B). Consistent with this, there was also a shift of 
circadian phase of carbohydrate levels of GalNac in Shp-/- mice with lower expression levels 
compared with ethanol-fed WT mice (Figure 4C). In the amino acid pathway, lower levels of 
β-alanine, 4-hydroxyproline, N-methylalanine and 4-aminobutyrate amino acids were found 
in livers of Shp-/- mice (Figure 4D). In particular, the oscillatory shift and amplitude of β-
alanine, 4-hydroxyproline and 4-aminobutyrate amino acids was noticeably altered by Shp-
deficiency in comparison to WT mice (Figure 4D). Increased levels of BCAAs valine, 
leucine and isoleucine, as well as AAAs glutamic acid, asparagine and phenylalanine were 
evident in Shp-/- mice at the onset of the light phase at ZT0 compared with WT mice (Figure 
4D-4E). In particular glutamic acid, valine, leucine, isoleucine, phenylalanine and 
asparagine showed a shift in circadian phase where it peaked at the onset of the light cycle 
and lower expression during the dark cycle compared with WT mice (Figure 4E).
Discussion
Analysis of serum metabolomes for markers of liver dysfunction have been extensively used 
to identify liver disease states, however majority of the studies have yet to provide thorough 
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screening beyond this level. Here we provide a novel and high throughput comparative 
oscillatory analysis of the serum metabolome compared with the liver metabolome over a 
24hr circadian cycle to elucidate the role of Shp and the deleterious effects of alcohol on the 
development of ALD.
The current study demonstrates that the majority of metabolites identified by GC-MS was 
found in the liver compared with the serum. The cycling of carbohydrates and lipids in 
particular, were predominately found in the liver compared with its presence in the serum. 
Indeed, the liver is the primary site of glucose uptake and glucose production, where the 
majority of the cycling carbohydrates (including glucose and fructose) are broken down and 
stored as glycogen and excess lipids undergo fatty acid oxidation and its energy is stored as 
fatty acids. The abundance of these particular metabolites from the carbohydrate and lipid 
pathways were either not detected or were below the detection limit in the serum compared 
with their abundance in the liver. Interestingly, there was a phase shift of serum aspartic acid 
and glutamic acid cycle where metabolite levels peaked during the dark cycle in Shp-/- mice 
by the maltose-binge diet. Aspartic acid and glutamic acid are two main excitatory 
neurotransmitters playing important roles in protecting the liver by aiding the removal of 
ammonia. High levels of ammonia in the system can result in severe liver dysfunction 
(Sawhney et al., 2016). This was also evident in liver where glutamic acid levels were higher 
in Shp-/- mice than in WT mice irrespective of diet consumed. The elevated levels may be 
associated with changes in the transsulfuration pathway previously reported where hepatic 
levels of betaine-homocysteine methyltransferase (Bhmt) and cystathionine gamma lyase 
(Cth) protein were significantly upregulated in Shp-deficient mice (Tsuchiya et al., 2015). 
These observations suggests that maltose-binge may have trigged a defensive response in 
Shp-/- mice in protecting the liver against harmful levels of toxic metabolites.
Although the majority of metabolites identified by the metabolomics analysis were present 
in both CD+M and ED+E feeding conditions, there were in fact differences between the two 
diets in both serum and liver despite a similar volume intake of the CD and ED that both WT 
and Shp-/- mice consumed. Furthermore, differences were also observed between the two 
genotypes under control conditions. The CD+M diet is rich in monosaccharides and 
disaccharides that are not present in normal chow diet; this is required for the purpose of 
balancing caloric intake from the ethanol diet. The lower levels of metabolites observed in 
the carbohydrate, lipid, pentose phosphate and nucleotide pathway in Shp-/- mice compared 
with WT mice under CD+M conditions suggest that lack of Shp may result in a fast turnover 
in the circulating levels of these metabolites. However the composition of the control 
maltose diet may affect to some extent the expression profile of particular metabolites 
compared with a regular chow diet. It is also worth noting that Shp-deficient mice treated 
with ED+E showed a similar low expression pattern in the carbohydrate, lipid and pentose 
phosphate pathways irrespective of the diet consumed. These distinct changes in individual 
metabolites altered by ethanol feeding and Shp-deficiency may correlate with changes in 
hepatic gene expression recently reported (Yang et al.; 2016, in press). Specifically, the 
lower expression levels may correlate with activating transcription factor-4 (ATF4) protein 
which was down regulated in Shp-/- compared with WT mice. The higher levels of liver lipid 
and carbohydrate metabolites in WT mice fed the ethanol diet was consistent with the 
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increased lipid accumulation, which was diminished in mice deficient for Shp (Yang et al., 
2016, in press).
The essential amino acids leucine, isoleucine and valine are classified as branched chain 
amino acids (BCAAs) which are poorly metabolized in the liver compared with other 
essential amino acids. Studies have previously reported that an imbalance between BCAA 
and AAA can lead to liver failure (Tajiri and Shimizu, 2013) as well as other diseases such 
as obesity, cardio-metabolic dysfunction and insulin resistance (Tajiri and Shimizu, 2013, 
Newgard et al., 2009, Wang et al., 2011). Majority of these studies have largely focused on 
AAAs phenylalanine and tyrosine because of its precursor with brain catecholamine and to a 
smaller extent, tryptophan, which is converted into the inhibitory neurotransmitter serotonin. 
In patients with advanced liver disease and liver cirrhosis, BCAA levels were found to be 
reduced while methionine and AAAs tyrosine and phenylalanine were increased (Morgan et 
al., 1978), possibly due to impaired hepatic metabolism and portal systemic shunting of 
blood. Patients with fulminant hepatic failure also had elevated levels of AAA but 
concentration levels of BCAA were largely normal (Chase et al., 1978).
In the current study, the modest increase in serum AAA levels (aspartic acid, glutamic acid, 
tyrosine, ornithine and tryptophan) in Shp-/- mice during the dark cycle were not associated 
with overt changes in serum BCAA (valine, leucine and isoleucine) levels. Although there 
was a shift in the oscillating profile of BCAAs and phenylalanine in livers of Shp -/- mice fed 
the alcohol diet, levels were moderately higher compared with WT mice, consistent with 
levels reported in serum. On the contrary, the lower expression levels of a number of amino 
acids including BCAAs (valine, leucine, isoleucine), glucogenic amino acids (glutamic acid, 
aspartic acid, glycine, alanine, proline) and AAAs (ornithine, tyrosine, tryptophan, 
asparagine) as well as other amino acids (serine, methionine, lysine, homoserine, glutamine) 
in WT mice fed the ethanol diet is intriguing and warrants further investigation. It is worth 
noting however, that serum ALT levels were transiently increased after a binge in WT mice 
fed the ED+E but returned to basal levels after 24 hours (Tsuchiya et al., 2015). While 
elevated levels of serum AST and ALT may point towards acute liver injury and reduced 
plasma BCAA is a hallmark of liver cirrhosis, the required levels need to reach a certain 
threshold for prominent signs of liver dysfunction. Our findings of reduced BCAA levels 
and elevated serum ALT previously reported in WT mice fed ED+E may be an indicator of 
early liver dysfunction that has yet to manifest. Nevertheless, it appears that Shp-deficiency 
may afford protection or at least delay the onset of liver dysfunction due to the elevated 
BCAA metabolite levels observed.
Several lines of evidence suggest that disruption of the circadian system may be a risk factor 
for alcohol-induced intestinal hyperpermeability, endotoxemia, dysbiosis and hepatic 
steatosis (Forsyth et al., 2015, Mutlu et al., 2009, Summa et al., 2013, Yan et al., 2011). Gut-
derived endotoxemia is a key cofactor of ALD and accumulative evidences have reported a 
strong correlation between plasma endotoxin levels and the severity of liver injury (Summa 
et al., 2013, Mutlu et al., 2009, Yan et al., 2011). Similarly, impairments in the circadian 
cycle leading to dysregulated lipid metabolism have been reported (Froy, 2010). Indeed, the 
increased steatosis reported in WT mice following exposure to chronic ethanol consumption 
may be associated with increased intestinal permeability and endotoxemia but further 
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investigation is warranted which is beyond the scope of the current study. Lower liver 
triglycerides levels were reported in Shp-/- mice in response to ED+E (Yang et al.; 2016, in 
press) which may be associated with the reduced circulating lipid metabolites observed in 
the current study.
This study provides a novel insight into the role of Shp and the effects of control maltose 
and alcohol on serum and liver metabolomes, and demonstrate that observations reported in 
the serum do not necessarily translate to the findings reported in the liver. On a whole, 
metabolomics analysis revealed distinct cyclic changes in metabolites by ethanol binge and 
Shp-deficiency and that prolonged ED+E feeding may further unmask a distinct phenotype 
compared with the mild changes observed in the current study. However, further studies 
including the use of RNA sequencing is warranted to link the metabolomics changes 
observed to a specific set of genes that may be altered by Shp-deficiency. Nevertheless, 
alterations in amino acid metabolite levels due to ethanol feeding highlight important 
characteristics that may provide therapeutic approaches into the diagnosis and prevention of 
ALD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Non-supervised multivariate data analysis of Metabolomics profiling
a) PLS-DA scores plot performed using two (top) or three (bottom) principal components 
corresponding to a model built using two or three latent variables aimed at discrimination 
among four groups. b) Heatmap showing differential abundance of metabolites in response 
to control maltose (CD+M) vs. ethanol diets (ED+E) in serum of wildtype (WT) and Shp-/- 
mice. Serum was collected from WT CD+M (dark blue), WT ED+E (light blue), Shp-/- CD
+M (red) and Shp-/- ED+EH (green) mice over a 24h light/dark (LD) cycle at Zeitgeber time 
ZT12, ZT18, ZT0 and ZT6 using the Gao-binge model. A GC/MS metabolomics analysis 
was used to identify specific metabolite pathways.
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Figure 2. Serum metabolites altered by maltose and ethanol diets in Shp-/- mice
a-c: Comparison of serum metabolites between wildtype (WT) and Shp-/- mice fed with 
control diet + maltose binge (CD+M). a) amino acid metabolites at Zeitgeber time (ZT) 12, 
b) nucleotide metabolites and c) amino acid metabolites over a 24h light/dark (LD) cycle. d-
f: Comparison between WT and Shp-/- mice fed with ethanol diet + ethanol binge (ED+E). 
d) lipid metabolites at ZT12, e) ribose metabolite and f) amino acid metabolites over a 24h 
LD cycle. Data are represented as means ± SEM (n=3/group). * P<0.05, Shp-/- versus WT. 
Serum was collected from WT CD+M (black open square), WT ED+E (red open square), 
Shp-/- CD+M (black closed square) and Shp-/- ED+E (red closed square) mice over a 24h 
LD cycle at ZT12, ZT18, ZT0 and ZT6 using the Gao-binge model. A GC/MS 
metabolomics analysis was used to identify specific metabolite pathways.
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Figure 3. Liver oscillatory metabolic pathways disrupted by maltose-diet in Shp-/- mice
a-d: Comparison of liver metabolites between wildtype (WT) and Shp-/- mice fed with 
control diet + maltose binge (CD+M). a) carbohydrate metabolites, b) pentose phosphate 
metabolites, c) nucleotide metabolites, and d) lipid metabolites in WT and Shp-/- mice. Data 
are represented as means ± SEM (n=3/group). * P<0.05, Shp-/- versus WT. Livers were 
collected from WT CD+M (black open square) and Shp-/- CD+M (black closed square) mice 
over a 24h LD cycle at Zeitgeber time ZT12, ZT18, ZT0 and ZT6. A GC/MS metabolomics 
analysis was used to identify specific metabolite pathways.
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Figure 4. Liver oscillatory metabolic pathways disrupted by ethanol-diet in Shp-/- mice
a-d: Comparison of liver metabolites between wildtype (WT) and Shp-/- mice fed with 
ethanol diet + ethanol binge (ED+E). a) lipid metabolites, b) nucleotide metabolites, c) 
carbohydrate metabolites, and d) amino acid metabolites in WT and Shp-/- mice. Data are 
represented as means ± SEM (n=3/group). * P<0.05, Shp-/- versus WT. Livers were 
collected from WT ED+E (red open square) and Shp-/- ED+E (red closed square) mice over 
a 24h light/dark (LD) cycle at Zeitgeber time ZT12, ZT18, ZT0 and ZT6 using the Gao-
binge model. A GC/MS metabolomics analysis was used to identify specific metabolite 
pathways.
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Table 1
Comparative metabolomics profile of metabolic pathways in serum and liver
Serum and liver were collected from wildtype (WT) control diet plus maltose-binge (CD+M), WT ethanol diet 
plus ethanol-binge (ED+E), Shp-/- CD+M and Shp-/- ED+E mice over a 24h light/dark (LD) cycle at Zeitgeber 
time ZT12, ZT18, ZT0 and ZT6 using the Gao-binge model. A GC/MS metabolomic analysis of serum and 
liver was performed to identify specific metabolites from the carbohydrate, amino acid, lipid, nucleotide, 
pentose phosphate and tricarboxylic acid (TCA) pathways.
Metabolic pathway Number of metabolites in serum (%) Number of metabolites in liver (%)
Total number of metabolites analyzed 80 110
Carbohydrates 10 (12.5%) 20 (18.1%)
Lipids 20 (25%) 28 (25.5%)
Amino acids 29 (36.25%) 29 (26.4%)
Nucleotides 7 (8.75%) 13 (12%)
Tricarboxylic acid 9 (11.25%) 9 (8%)
Urea 2 (2.5%) 3 (3%)
Others 3 (3.75%) 8 (7%)
% of metabolites rhythmic under ED+E 91% 87%
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